Novartis suspended multiple studies of a CAR T candidate after three patients who received the therapy suffered fatal cases ...
Roche has tapped Simcere Zaiming for a new T cell engager that could have broad application in B cell–mediated diseases ...
After downsizing by 50% last year, Arsenal Biosciences is again laying off employees. This time, 99 people are getting cut as ...
The U.S. is scrambling to compete with a strategically positioned China on the biotech stage as the Asian country surpasses ...
Astellas Pharma, BridgeBio, BeOne Medicines and six other large biotechs join the 17 Big Pharmas that previously signed on to ...
Biomarin has granted Ascendis a non-exclusive, worldwide license to use navepegritide, the active ingredient in the latter ...
The FDA granted the approval of Revolution Medicines' daraxonrasib, now to be known as Rasonque, in pancreatic adenocarcinoma ...
Current leaders Eli Lilly and Novo Nordisk have cornered the early market for weight loss therapeutics, but several other ...
Biopharmas developing CAR T therapies for autoimmune indications face major barriers to maximizing the market. Advances in ...
Teva Pharmaceuticals is the 'stalking horse bidder' to kick off the auction process for BioXcel Therapeutics' AI-derived ...
With the approval, Eli Lilly’s Mounjaro becomes the first dual GIP/GLP-1 receptor agonist indicated to lower the risk of ...
If Heidi Overton clears the Senate nomination process, analysts say she will have a tough job ahead to “restore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results